Navigation Links
Early Stage, Step 9: Raising capital in the securities landscape

Editor's note: This is the ninth in a series of articles on developing start-up companies in the technology or biotechnology sectors. The most recent article focused on worker classification.

Madison, Wis. - The idea is developed. Lawyers and accountants are on board. The intellectual property has been protected. The entity is formed. The name ......

Full article >>> ompany does not have to register with the state securities commissioner, now housed within the Department of Financial Institutions.

Notwithstanding the fact that you are raising money from family and friends, the new company must provide adequate disclosure. Adequate disclosure amounts to: financial statements for the new company, including past, current......

Full article >>> nd that their money is illiquid, that it is not going to be repaid anytime soon.

This is just the beginning on securities laws. Next time, I will delve further into them, including discussions on the federal laws.

Previous Early-Stage articles by Joe Boucher

Early Stage, Step 8: Misclassifying workers brings......

Full article >>> liability or responsibility for any claims made or opinions expressed herein.......

Full article >>>
'"/>

Source:wistechnology.com By Joe Boucher 03/29/07


Related biology technology :

1. Early Stage: Step 11 - Other forms of finance
2. Early Stage 10: The nuances of federal laws
3. Early Stage, Step 8: Misclassifying workers brings risk
4. Early Stage 7, Part I: Just what is an employee?
5. Early Stage: Step 6 - Taxes, taxes, taxes!
6. Early Stage: Step 5 - Forming the entity
7. Early Stage, Step 4: Cautionary trademark tales
8. Early Stage, Step 3: Naming the entity
9. Early-stage quality brings investment, Meier says
10. Early-stage executives hear from investors
11. Early Stage Step 2: Choosing a domain name
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)...  Global demand for enzymes is forecast to ... $7.2 billion.  This market includes enzymes used in ... production, animal feed, and other markets) and specialty ... and beverages will remain the largest market for ... products containing enzymes in developing regions.  These and ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly ... technologies, services and solutions to the healthcare market. The company's primary focus is ... manufacturing, sales and marketing strategies that are necessary to help companies efficiently bring ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
Breaking Biology Technology:
(Date:6/7/2016)... -- Syngrafii Inc. and San Antonio Credit Union (SACU) ... Syngrafii,s patented LongPen™ eSignature "Wet" solution into SACU,s ... in greater convenience for SACU members and operational ... document workflow and compliance requirements. Logo ... Highlights: ...
(Date:6/2/2016)... --  The Weather Company , an IBM Business (NYSE: ... in which consumers will be able to interact with IBM ... voice or text and receive relevant information about the product ... have long sought an advertising solution that can create a ... and valuable; and can scale across millions of interactions and ...
(Date:5/24/2016)... IRVINE, Calif. , May 24, 2016 Ampronix facilitates superior patient care ... LMD3251MT  3D medical LCD display is the latest premium product recently added to ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):